Studies on evaluation of anaesthetic quality and clinico-physiological effects of xylazine and fentanyl as premedicants to zolazepam-tiletamine-isoflurane anaesthesia in canine

Read full text Summarise with VIRAT
Authors: Manisha Jaiswal, SK Tiwari, MO Kalim, Jashwanth Gowda, Prakhar Jaiswal, Alok Kumar Jaiswal
Cited by: 0
References: 42

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

To assess the clinical and physiological outcomes of xylazine and fentanyl premedication in dogs undergoing zolazepam-tiletamine-isoflurane anaesthesia, eighteen clinical cases were evaluated. Following baseline atropine administration, the subjects were randomly divided into three groups: Group I (zolazepam-tiletamine alone), Group II (xylazine) and Group III (fentanyl). Anaesthesia was intravenously induced using zolazepam-tiletamine and subsequently sustained with isoflurane, while vital parameters were assessed at set time points. Results indicated that the xylazine regimen delivered enhanced sedation, analgesia and muscle relaxation, concurrently extending the duration of anaesthesia. The fentanyl protocol, while providing moderate analgesic and sedative effects, demonstrated highly stable hemodynamics. Conclusively, both premedication combinations are safe, viable options for canine anaesthesia that effectively maintains vital parameters within acceptable physiological boundaries.

Fields of Study & Subjects

Veterinary Pharmacology and Anesthesia Anesthesia and Sedative Agents Veterinary Medicine and Surgery

Publication details

Journal / source
International Journal of Advanced Biochemistry Research
Volume
10
Issue
3
Pages
687–698
Publication date
1 March 2026
Language
EN